Guardian Pharmacy Services, INC Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 6.5% of Guardian Pharmacy Services Inc.'s Class A Common Stock as of March 31, 2026.

Brown Advisory Inc. and its affiliates have disclosed a 4.54% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Common Stock.

Wellington Management Group and its affiliates have filed an amended Schedule 13G, reporting a 3.1% beneficial ownership stake in Guardian Pharmacy Services, Inc. as of December 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.2% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Stock.

J. Goldman & Co. and affiliates reported a 2.89% beneficial ownership stake in Guardian Pharmacy Services, Inc. common stock via an amended Schedule 13G.

Wellington Management Group LLP and its affiliates have reported a 5.0% beneficial ownership stake in Guardian Pharmacy Services, Inc. common stock.

BlackRock, Inc. has reported a 5.7% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Stock as of September 30, 2025.

Wellington Management Group LLP and its affiliates have disclosed a 4.9% beneficial ownership stake in Guardian Pharmacy Services, Inc. common stock as of June 30, 2025.

ClearBridge Investments, LLC has reported a 2.0% beneficial ownership stake in Guardian Pharmacy Services, Inc., holding 445,524 shares of Class A Common Stock.

Franklin Resources, Inc. and its affiliates have reduced their beneficial ownership in Guardian Pharmacy Services, Inc. to 4.3% of Class A Common Stock.

The Vanguard Group has filed an amended Schedule 13G, revealing a 4.25% beneficial ownership stake in Guardian Pharmacy Services Inc. common stock.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.0% beneficial ownership of Class A Stock in Guardian Pharmacy Services, Inc. as of June 30, 2025.

Teachers Advisors, LLC and its affiliated entities have filed an amended Schedule 13G, confirming a combined beneficial ownership of 2.41% of Guardian Pharmacy Services, Inc. common stock, held for ordinary course investment purposes.

TIAA-CREF Investment Management, LLC, along with its affiliates, has disclosed a beneficial ownership of 2.41% in Guardian Pharmacy Services, Inc. common stock as of May 30, 2025.

Nuveen Asset Management, LLC and its affiliated entities have filed an amended Schedule 13G, revealing a collective passive beneficial ownership of 2.41% in Guardian Pharmacy Services, Inc.

Wellington Management Group LLP and its affiliated entities have reported a 5.05% beneficial ownership stake in Guardian Pharmacy Services, Inc. common stock as of March 31, 2025.

ClearBridge Investments, LLC has filed an amended Schedule 13G, reporting a 5.6% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Common Stock.

Franklin Resources, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 8.0% of Guardian Pharmacy Services, Inc.'s Class A Common Stock as of March 31, 2025.

Brown Advisory Inc. and its affiliates have filed an amended Schedule 13G, disclosing a collective beneficial ownership of 7.1% of Guardian Pharmacy Services, Inc.'s Class A Common Stock as of March 31, 2025.

Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a passive beneficial ownership of 4.66% in Guardian Pharmacy Services, Inc.'s Class A Common Stock as of December 31, 2024.

Woodline Partners LP has filed an amended Schedule 13G, reporting a 4.5% beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Common Stock as of December 31, 2024.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.42% in Guardian Pharmacy Services, Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.3% beneficial ownership stake in Guardian Pharmacy Services, Inc. as of December 31, 2024.

The Vanguard Group has filed a Schedule 13G, reporting a 6.5% passive beneficial ownership stake in Guardian Pharmacy Services Inc. as of December 31, 2024.

Brown Advisory Inc. and its affiliated entities have reported a combined beneficial ownership of 17.4% of Guardian Pharmacy Services, Inc.'s Class A Common Stock as of December 31, 2024.

Ophir Asset Management Pty Ltd has filed an amended Schedule 13G, reporting a 1.8% passive beneficial ownership stake in Guardian Pharmacy Services, Inc.'s Class A Ordinary Shares.